Miyata Kazunori, Yamagami Satoru, Nejima Ryouhei, Miyai Takashi, Shimizu Kentaro, Amano Shiro
Miyata Eye Hospital, Miyakonojo, Miyazaki, Japan.
Cornea. 2005 Nov;24(8):962-6. doi: 10.1097/01.ico.0000159757.28607.ae.
To determine the influence of dispersive ophthalmic viscosurgical products (OVPs) on corneal endothelial cell (CEC) density during penetrating keratoplasty (PKP) and on the postoperative intraocular pressure (IOP).
In 117 eyes of 113 patients, PKP was performed by a single surgeon from April 1, 1998 to April 30, 2002. Loss of CECs and postoperative IOP were evaluated retrospectively after use of Viscoat (sodium hyaluronate 3.0%, chondroitin sulfate 4.0%) plus Healon (sodium hyaluronate 1.0%) (Viscoat/Healon group) or Healon alone (Healon group) during surgery.
The average CEC loss was 14.6 +/- 15.5% and 9.0 +/- 10.5% at 1 month, 18.1 +/- 14.6% and 10.1 +/- 7.3% at 3 months, 20.1 +/- 16.3% and 12.2 +/- 10.9% at 6 months, and 31.7 +/- 21.4% and 18.1 +/- 15.5% at 12 months in the Healon (n = 74) and Viscoat/Healon (n = 43) groups, respectively. Patients were stratified into groups with corneal leukoma (n = 61) or bullous keratopathy (n = 56). Loss of CECs was significantly smaller in the Viscoat/Healon group compared with the Healon group irrespective of whether patients had corneal leukoma or bullous keratopathy at 3, 6, and 12 months postoperatively. There was no significant difference of postoperative IOP between the Healon and Viscoat/Healon groups over 12 months of follow-up.
These results suggest that the addition of Viscoat to Healon decreases CEC loss during PKP and does not affect postoperative IOP.
确定在穿透性角膜移植术(PKP)期间,分散性眼科粘弹剂产品(OVP)对角膜内皮细胞(CEC)密度以及术后眼压(IOP)的影响。
在1998年4月1日至2002年4月30日期间,由同一位外科医生对113例患者的117只眼睛进行PKP手术。回顾性评估在手术中使用Viscoat(3.0%透明质酸钠,4.0%硫酸软骨素)加Healon(1.0%透明质酸钠)(Viscoat/Healon组)或仅使用Healon(Healon组)后CEC的损失情况和术后眼压。
Healon组(n = 74)和Viscoat/Healon组(n = 43)在术后1个月时CEC平均损失分别为14.6±15.5%和9.0±10.5%,3个月时分别为18.1±14.6%和10.1±7.3%,6个月时分别为20.1±16.3%和12.2±10.9%,12个月时分别为31.7±21.4%和18.1±15.5%。患者被分为角膜白斑组(n = 61)或大疱性角膜病变组(n = 56)。无论患者是角膜白斑还是大疱性角膜病变,术后3、6和12个月时,Viscoat/Healon组的CEC损失均显著低于Healon组。在12个月的随访期内,Healon组和Viscoat/Healon组的术后眼压无显著差异。
这些结果表明,在Healon中添加Viscoat可减少PKP期间的CEC损失,且不影响术后眼压。